Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma

Ibrahim Sadek, Angela Dispenzieri, Morie A. Gertz, Shaji Kumar

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma'. Together they form a unique fingerprint.